Rui-Jie Luo

Rui-Jie Luo

Auto-generated profile, based on publicly available information

Rui-Jie Luo

Department of Integrated Traditional Chinese and Western Medicine, West China Hospital of Sichuan University, Chengdu, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CZChen-Long Zhang
Chen-Long Zhang
ZLZi-Qi Lin
Zi-Qi Lin
RLRui-Jie Luo
Rui-Jie Luo
XZXiao-Xin Zhang
Xiao-Xin Zhang
JGJia Guo
Jia Guo
QXQing Xia
Qing Xia
Chai‐Qin‐Cheng‐Qi decoction (CQCQD) improves intestinal motility in acute pancreatitis (AP), but the mechanism(s) require elucidation. We investigated the effects of CQCQD and carbachol, a prokinetic agent, on colonic smooth muscle cells (SMCs) in L‐arginine‐induced necrotising AP model in rats. In treatment groups, intragastric CQCQD (20 g/kg, 2 hourly × 3 doses) or intraperitoneal carbachol (60 μg/kg) was given 24 hours after induction of AP. Both CQCQD and carbachol decreased the severity of pancreatic and colonic histopathology (all P < 0.05). Both CQCQD and carbachol reduced serum intestinal fatty acid binding protein, vasoactive intestinal peptide, and substance P and increased motility levels. CQCQD upregulated SMC phospholipase C‐beta 1 (PLC‐β1) mRNA and PLC protein (both P < 0.05), while both treatments upregulated protein kinase C‐alpha (PKC‐α) mRNA and PKC protein and downregulated adenylate cyclase (AC) mRNA and protein compared with no treatment (all P < 0.05). Neither treatment significantly altered L‐arginine‐induced PKC‐β1 and PKC‐ε mRNA reduction. Both treatments significantly increased fluorescence intensity of SMC intracellular calcium concentration (3563.5 and 3046.9 versus 1086.9, both P < 0.01). These data suggest CQCQD and carbachol improve intestinal motility in AP by increasing in colonic SMCs via upregulating PLC, PKC and downregulating AC.

24 December 2017 in Disease Markers
Verified
Journal Article
Open access
PDF file
NSNa Shi
Na Shi
LDLihui Deng
Lihui Deng
WCWeiwei Chen
Weiwei Chen
XZXiaoxin Zhang
Xiaoxin Zhang
RLRuijie Luo
Ruijie Luo
QXQing Xia
Qing Xia
Background and Aims. The aim of this study was to determine the expression of microRNA-127 (miR-127) in both rat models and patients of acute pancreatitis (AP) with lung injury (LI). Methods. Rats were administrated with retrograde cholangiopancreatography injection of 0.5% or 3.5% sodium taurocholate to induce AP with mild or severe LI and were sacrificed at 6, 12, and 24 h. Rats from the control group received a laparotomy only. Plasma from a prospective cohort of AP patients was collected. The levels of miR-127 in the tissues and plasma were detected using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Results. The upregulation of miR-127 in the lungs of rats was detected in the groups of AP with severe LI at 6 h and 24 h, whereas it was scarcely detectable in plasma. In the pilot study that included 18 AP patients and 5 healthy volunteers, the plasma miR-127 level was significantly downregulated in AP patients with respiratory failure compared with the healthy volunteers (P=0.014) and those without respiratory failure (P=0.043). Conclusion. miR-127 might serve as a potential marker for the identification of AP with LI.